AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $588,435 | -72.2% | 10,239 | -81.9% | 0.02% | -74.1% |
Q1 2023 | $2,118,900 | +109.0% | 56,504 | +56.2% | 0.06% | +100.0% |
Q4 2022 | $1,013,904 | +36.3% | 36,185 | +36.6% | 0.03% | +11.5% |
Q3 2022 | $744,000 | -31.8% | 26,482 | -15.6% | 0.03% | -46.9% |
Q2 2022 | $1,091,000 | -16.5% | 31,363 | -13.8% | 0.05% | -19.7% |
Q1 2022 | $1,307,000 | +329.9% | 36,405 | +179.1% | 0.06% | +221.1% |
Q4 2021 | $304,000 | +32.8% | 13,042 | +4.3% | 0.02% | -9.5% |
Q1 2021 | $229,000 | -57.5% | 12,503 | -47.9% | 0.02% | -43.2% |
Q2 2020 | $539,000 | +36.8% | 23,980 | +20.8% | 0.04% | +8.8% |
Q3 2019 | $394,000 | +64.2% | 19,853 | +68.9% | 0.03% | +100.0% |
Q1 2019 | $240,000 | +57.9% | 11,754 | +12.0% | 0.02% | -10.5% |
Q1 2017 | $152,000 | -22.8% | 10,493 | -1.6% | 0.02% | -38.7% |
Q4 2016 | $197,000 | -51.8% | 10,669 | -68.7% | 0.03% | -35.4% |
Q1 2016 | $409,000 | -11.1% | 34,093 | +5.6% | 0.05% | +17.1% |
Q4 2015 | $460,000 | -43.8% | 32,300 | -30.7% | 0.04% | -55.4% |
Q2 2015 | $819,000 | – | 46,614 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
Summit Global Investments | 47,546 | $871,000 | 0.06% |
WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |